Madrigal Pharmaceuticals (MDGL) Payables (2019 - 2025)
Historic Payables for Madrigal Pharmaceuticals (MDGL) over the last 13 years, with Q3 2025 value amounting to $44.9 million.
- Madrigal Pharmaceuticals' Payables fell 222.99% to $44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.9 million, marking a year-over-year decrease of 222.99%. This contributed to the annual value of $43.6 million for FY2024, which is 5548.3% up from last year.
- As of Q3 2025, Madrigal Pharmaceuticals' Payables stood at $44.9 million, which was down 222.99% from $38.0 million recorded in Q2 2025.
- In the past 5 years, Madrigal Pharmaceuticals' Payables registered a high of $46.0 million during Q3 2024, and its lowest value of $1.1 million during Q2 2021.
- Over the past 5 years, Madrigal Pharmaceuticals' median Payables value was $21.4 million (recorded in 2021), while the average stood at $22.8 million.
- Examining YoY changes over the last 5 years, Madrigal Pharmaceuticals' Payables showed a top increase of 200226.16% in 2021 and a maximum decrease of 7867.71% in 2021.
- Madrigal Pharmaceuticals' Payables (Quarter) stood at $21.4 million in 2021, then increased by 11.46% to $23.8 million in 2022, then rose by 17.67% to $28.0 million in 2023, then soared by 55.48% to $43.6 million in 2024, then grew by 3.08% to $44.9 million in 2025.
- Its Payables stands at $44.9 million for Q3 2025, versus $38.0 million for Q2 2025 and $42.1 million for Q1 2025.